Skip to content

Biomagnetic Characterization of Gastric Dysrhythmias III

Biomagnetic Characterization of Gastric Dysrhythmias III

Status
Completed
Phases
Early Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03176927
Enrollment
22
Registered
2017-06-06
Start date
2012-12-28
Completion date
2021-05-19
Last updated
2026-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Nausea, Diabetic Gastroparesis, Diabetics Without Symptoms of Gastroparesis, Functional Dyspepsia, Idiopathic Gastroparesis, Total or Partial Gastrectomy

Keywords

magnetogastrogram, gastroparesis, electrogastrogram, gastric slow wave

Brief summary

There is a tremendous clinical need for a noninvasive technique that can assess gastric electrical activity and would be repeatable without any exposure to radiation. Investigators developed a new technique allowing to use noninvasive methods to assess bioelectrical activity in the gastrointestinal system. This has enabled to characterize the normal and pathologic physiology of the stomach through the use of noninvasive magnetogastrogram (MGG) records. Primary hypothesis for this proposal is that analysis of gastric slow wave uncoupling and propagation in multichannel MGG discriminates between normal and pathological gastric electrical activity. Eventually, investigators envision this research leading to new insights for gastrointestinal conditions such as gastroparesis, functional dyspepsia and chronic idiopathic nausea that would inform clinical management of these debilitating diseases.

Detailed description

5/23/25. Study record updated to reflect Early Phase 1/Phase 0 trial. The main aim of the study was to evaluate MGG as a device for classification of functional gastric disorders. Studies have demonstrated that the magnetogastrogram (MGG) records the same gastric slow wave activity that detect with serosal and mucosal electrodes. The upgraded magnetometer will improve the spatial resolution resulting in increased sensitivity for detecting and characterizing both abnormal frequency dynamics and abnormal spatiotemporal patterns. The spatiotemporal data collected with multichannel Superconducting QUantum Interference Device (SQUID) biomagnetometer has allowed , for the first time, to characterize propagation of the gastric slow wave noninvasively. In addition to frequency dynamic changes, which are the only reliable parameters from cutaneous electrogastrogram (EGG), and which still do not necessarily correlate well with disease, the MGG reflects normal and abnormal gastric slow wave activity. Furthermore, for the first time, investigators have demonstrated that propagation characteristics determined magnetically distinguish normal subjects from patients with gastroparesis. Also for the first time, investigators have been able to detect the gradient in gastric propagation velocity noninvasively in animal subjects. However, investigators still have unresolved questions about how MGG propagation rhythm and pattern disturbances may specify functional disorders.

Interventions

DIAGNOSTIC_TESTmagnetogastrogram

Sponsors

Vanderbilt University Medical Center
Lead SponsorOTHER
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
12 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Participants between ages 12-80 * Diabetic patients with gastroparesis, diabetic patients without gastroparesis and who are willing to have a gastric emptying test if they have not had one in the last 6 months and an IV inserted. * Patients with idiopathic gastroparesis * Total or partial gastrectomy patients * Children (ages 12-17) with functional dyspepsia * Children (ages 12-17) with chronic nausea

Exclusion criteria

* Those with claustrophobia who cannot lie still under the SQUID for the length of time required. * Normal participants with known intestinal complications * Pregnant females (females who are able to have children will be given a pregnancy test). * Morbid obesity (these patients are presumably unable to lie under the current generation of SQUID devices). * Patients with a history of cardiac arrhythmias, taking anticoagulants, or greater than 80 years of age will be excluded.

Design outcomes

Primary

MeasureTime frame
Measurement of gastric slow wave activity in normal and diseased smooth muscle of the stomach1 day

Secondary

MeasureTime frame
Measurement of gastric slow wave propagation velocity in gastroparesis patients1 day
Measurement of invasive serosal electromyogram before and after partial/total gastrectomy.day 1 and day 30
Measurement of noninvasive magnetogastrogram before and after partial/total gastrectomy.day 1 and day 30
Noninvasive measurement of gastric slow wave dysrhythmia in pediatric patients with nausea and functional dyspepsia1 day

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORLeonard A Bradshaw, PhD

Vanderbilt University Medical Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 23, 2026